Lattis sits at the center of your IP estate.

Ask the field by meaning, learn the whitespace you don’t cover, and watch every rival — with the current owner and a status signal on every result.

app.withlattis.com/search
CPC A61K · A61PGrant year 2019–2024Assignee AnyStatus Active
312 patents · ranked by semantic relevancesort: relevance ↓
96
similar
GLP-1/GIP dual agonist with extended half-life for type 2 diabetes
Mar 14, 2024·Eli Lilly and Company·US 11,842,019 B2
Matched in: Claim

A selective dual agonist of GLP-1 and GIP receptors comprising a fatty-acid acyl moiety conferring once-weekly subcutaneous dosing in human subjects with type 2 diabetes mellitus…

91
similar
Bispecific anti-PD-L1/VEGF antibody for solid tumor immunotherapy
Sep 4, 2023·Regeneron Pharmaceuticals·US 11,517,602 B2
Matched in: Abstract

A recombinant bispecific binding molecule that simultaneously engages programmed death-ligand 1 (PD-L1) and vascular endothelial growth factor A (VEGF-A) for the treatment of advanced solid tumors…

84
similar
mRNA lipid-nanoparticle formulation for personalized neoantigen cancer vaccines
Jul 12, 2022·Moderna, Inc.·US 10,968,211 B2
Matched in: Description

An ionizable cationic lipid composition encapsulating in vitro-transcribed messenger RNA encoding tumor-associated neoantigens, formulated as a lipid nanoparticle for intramuscular administration…

app.withlattis.com/whitespace
Whitespace · your cardiometabolic estateTargets and modalities active in the field that your portfolio doesn’t cover yet.
3 uncovered opportunities · ranked by gap scoresort: gap ↓
92
gap
Oral small-molecule GLP-1 receptor agonist
Field: 47 patents·You: 0·Small molecule
Coverage: Uncovered
78
gap
Amylin / GLP-1 dual co-agonist peptide
Field: 23 patents·You: 1·Peptide
Coverage: Thinly covered
71
gap
Once-monthly depot injectable formulation
Field: 12 patents·You: 0·Formulation
Coverage: Uncovered
app.withlattis.com/competitors/novo-nordisk
Novo Nordisk · competitor watchNew filings, targets, and modalities as they emerge — scored against your estate.
6 new filings this quarter · 34% overlap with your estatesort: recent ↓
88
signal
Oral semaglutide absorption-enhancer co-formulation
Nov 2024·Cardiometabolic·US 12,014,882
Signal: overlaps your estate
83
signal
GLP-1 / GIP / glucagon tri-agonist for MASH
Sep 2024·Metabolic · liver·US 11,986,501
Signal: overlaps your estate
76
signal
Extended-release microsphere delivery platform
Jul 2024·Drug delivery·US 11,952,410
Signal: overlaps your estate
One corpus. Every assignee. Every field.
Eli LillyNovo NordiskPfizerRegeneronModernaRocheProcter & Gamble

Ask the field. Learn what’s missing. Watch every rival.

Three capabilities on one continuous layer — each result carrying the current owner and a status signal to verify.

AskSemantic Search

Ask any patent question in plain language.

Search patents and the assets they protect by meaning, not just keywords. Lattis ranks claim-level matches and surfaces the current owner and a status signal to verify.

  • Claim-level matches, ranked by meaning
  • Current owner on every result
  • Status signal to verify at source
LearnWhitespace Engine

Learn what to pursue next.

Lattis learns your estate and the field around it, then identifies the targets and modalities you don't cover yet — and ranks the assets worth pursuing.

  • Gaps in your coverage, surfaced
  • Assets worth pursuing, ranked
  • A shortlist, not a landscape
WatchCompetitive Tracking

Watch any rival. Track where they're moving.

Benchmark your estate against any competitor and track new filings, targets, and modalities as they emerge.

  • Benchmark against any competitor
  • New filings, targets, modalities
  • Track movement as it emerges

IP runs on scattered tools and stale answers.

The asset that fits your pipeline may be described in different language, buried under an adjacent classification, or held by an owner you weren’t watching. Meanwhile, your own estate ages in a spreadsheet no one has opened in a quarter.

Lattis brings it into one workspace: ask the field by meaning, learn the whitespace you don’t cover, and watch the estates your rivals are building — with ownership and status attached to every result.

From your estate to the whole field.

Lattis does the work; you get the answer.

01
Search

Ask the field.

Query by target, mechanism, or claim language. Or upload your own patents. Lattis resolves, clusters, and analyzes the corpus into technology groups.

02
Understand

Get the answer, not another landscape.

See ranked matches, ownership, and status signals. On your own estate, understand coverage, claim mix, exclusivity cliffs, and licensed-out assets.

03
Act

Find what's missing and who's moving.

Lattis surfaces targets and modalities your portfolio doesn't cover and benchmarks your estate against competitors. Follow any result back to the underlying patent.

See how the pieces connect.

Lattis connects your estate to the broader field — linking patents to technology groups, targets, modalities, and owners. The result is a living view of what you have, what’s missing, and who’s moving.

Pipeline gapCardiometabolicOncologyVaccinesUS 11,842,019US 11,203,633US 11,517,602US 10,968,211WhitespaceEli LillyRegeneronModerna
Pipeline gap Technology area Top-ranked patent Other patent Institution Whitespace
Powered by a proprietary IP knowledge graph.

Evidence you can take into the room.

Every result is traceable, your data stays yours, and Lattis is built to inform the call — not make it for you.

Your data stays yours

Uploaded estates and queries are never shared or used to train models. Your book of business stays yours alone.

Every result is traceable

Each match carries its patent number, current owner, and a status signal you can verify at the source.

Intelligence, not legal advice

Lattis surfaces and ranks the field. Freedom-to-operate, exclusivity, and licensing decisions remain with your team and counsel.

From patent data to decisions.

Traditional patent databases help you search. Consultants help you answer a question. Lattis continuously connects your estate to the field around it — so you can search, identify whitespace, and track competitors from the same corpus.

LattisTraditional databasesConsultants
SearchSemantic, claim-levelKeyword / classificationProject-specific
OwnershipCurrent owner + status signalHistorical or static ownershipResearch-dependent
Your estatePortfolio intelligenceSeparate analysisCustom project
WhitespaceRanked opportunitiesLandscape outputOne mandate at a time
Competitive trackingContinuousManualPeriodic
OutputActionable shortlistSearch results / landscapeStrategic recommendation

See what your competitors miss.

Early access for a small group of licensing, BD, and IP teams. Search semantically, surface whitespace, track competitors, and export your findings in one click.

Free during the pilot · No credit card required
Lattis — The intelligence layer for your IP estate